TheraRadar
Clinical-Stage Companies / Anavex Life Sciences

Anavex Life Sciences

Pre-Approval PRO BETA
🔴

Stale Activity

No new clinical trials started in 2+ years. Activity may be declining or company may be focusing on existing programs. Last trial started: 3/15/2024

11
Total Trials
4
Phase 3
9
Phase 2
1
Recruiting
135
Score

Pipeline by Phase

Phase 3
4
Phase 2
9
Phase 1
1

Therapeutic Focus

Rett Syndrome Alzheimer Disease Alzheimer's Disease Schizophrenia Parkinson Disease Dementia

Clinical Trials (11)

NCT03941444 Phase 3 COMPLETED

ANAVEX2-73 Study in Patients With Rett Syndrome

Started: 5/6/2019

NCT06245213 Phase 2 ACTIVE NOT RECRUITING

A Study of ANAVEX3-71 in Adults With Schizophrenia

Started: 3/15/2024

NCT04314934 Phase 2 COMPLETED

OLE of Phase 2b/3 Study ANAVEX2-73-AD-004

Started: 10/10/2019

NCT04304482 Phase 2 COMPLETED

ANAVEX2-73 Study in Pediatric Patients With Rett Syndrome

Started: 7/1/2020

NCT04575259 Phase 2 COMPLETED

OLE Study for Patients With Parkinson's Disease With Dementia Enrolled in Study ANAVEX2-73-PDD-001

Started: 10/10/2019

NCT03790709 Phase 2 COMPLETED

ANAVEX2-73 for Treatment of Early Alzheimer's Disease

Started: 7/3/2018

NCT03758924 Phase 2 COMPLETED

Study of ANAVEX2-73 in Patients With Rett Syndrome

Started: 2/28/2019

NCT02756858 Phase 2 COMPLETED

An Extension Study of ANAVEX2-73 in Patients With Mild to Moderate Alzheimer's Disease

Started: 3/1/2016

NCT03774459 Phase 2 COMPLETED

ANAVEX2-73 Study in Parkinson's Disease Dementia

Started: 7/9/2018

NCT02244541 Phase 2 COMPLETED

Phase 2a Dose Finding, PK/PD and 12 Month Exploratory Efficacy Study of ANAVEX2-73 in Patients With Alzheimer's Disease

Started: 12/1/2014

NCT04442945 Phase 1 COMPLETED

Phase 1 Study of ANAVEX3-71

Started: 7/3/2020

Drug Candidates

ANAVEX3-71 oral capsules Placebo oral capsules ANAVEX2-73 ANAVEX2-73 oral liquid Placebo oral liquid High dose ANAVEX2-73 Mid dose ANAVEX2-73 Placebo oral capsule Placebo ANAVEX3-71
Activity Status: Stale
Last Trial Started: 3/15/2024
Last Trial Ended: 6/14/2024
Trials (12 months): 0
Completed Trials: 10
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.